These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28427814)

  • 1. Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1'-P2' ligands.
    Ghosh AK; Brindisi M; Yen YC; Cárdenas EL; Ella-Menye JR; Kumaragurubaran N; Huang X; Tang J; Mesecar AD
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2432-2438. PubMed ID: 28427814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand.
    Ghosh AK; Ghosh K; Brindisi M; Lendy EK; Yen YC; Kumaragurubaran N; Huang X; Tang J; Mesecar AD
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2605-2610. PubMed ID: 29970308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
    Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Selective and Potent Human β-Secretase 2 (BACE2) Inhibitors against Type 2 Diabetes: Design, Synthesis, X-ray Structure and Structure-Activity Relationship Studies.
    Ghosh AK; Brindisi M; Yen YC; Lendy EK; Kovela S; Cárdenas EL; Reddy BS; Rao KV; Downs D; Huang X; Tang J; Mesecar AD
    ChemMedChem; 2019 Mar; 14(5):545-560. PubMed ID: 30637955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.
    Ng RA; Sun M; Bowers S; Hom RK; Probst GD; John V; Fang LY; Maillard M; Gailunas A; Brogley L; Neitz RJ; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Adler M; Yao N; Zmolek W; Nakamura D; Quinn KP; Sauer JM; Bova MP; Ruslim L; Artis DR; Yednock TA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4674-9. PubMed ID: 23856050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.
    Tarazi H; Odeh RA; Al-Qawasmeh R; Yousef IA; Voelter W; Al-Tel TH
    Eur J Med Chem; 2017 Jan; 125():1213-1224. PubMed ID: 27871037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
    Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
    Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design, synthesis and biological evaluation of novel β-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand.
    Ghosh AK; Brindisi M; Yen YC; Xu X; Huang X; Devasamudram T; Bilcer G; Lei H; Koelsch G; Mesecar AD; Tang J
    Bioorg Med Chem Lett; 2015 Feb; 25(3):668-72. PubMed ID: 25537272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New N(4)-substituted piperazine naphthamide derivatives as BACE-1 inhibitors.
    Laras Y; Garino C; Dessolin J; Weck C; Moret V; Rolland A; Kraus JL
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):181-7. PubMed ID: 18770069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase.
    Hom RK; Gailunas AF; Mamo S; Fang LY; Tung JS; Walker DE; Davis D; Thorsett ED; Jewett NE; Moon JB; John V
    J Med Chem; 2004 Jan; 47(1):158-64. PubMed ID: 14695829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation.
    Edraki N; Firuzi O; Fatahi Y; Mahdavi M; Asadi M; Emami S; Divsalar K; Miri R; Iraji A; Khoshneviszadeh M; Firoozpour L; Shafiee A; Foroumadi A
    Arch Pharm (Weinheim); 2015 May; 348(5):330-7. PubMed ID: 25787800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent beta-secretase (bace-1) inhibitors by the synthesis of isophthalamide-containing hybrids.
    Zhu YP; Xiao K; Yu HP; Ma LP; Xiong B; Zhang HY; Wang X; Li JY; Li J; Shen JK
    Acta Pharmacol Sin; 2009 Feb; 30(2):259-69. PubMed ID: 19169270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.
    Al-Tel TH; Al-Qawasmeh RA; Schmidt MF; Al-Aboudi A; Rao SN; Sabri SS; Voelter W
    J Med Chem; 2009 Oct; 52(20):6484-8. PubMed ID: 19788239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position.
    Hamada Y; Nakanishi T; Suzuki K; Yamaguchi R; Hamada T; Hidaka K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4640-4. PubMed ID: 22726930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of potent and selective BACE-1 inhibitors.
    Björklund C; Oscarson S; Benkestock K; Borkakoti N; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist A; Samuelsson B
    J Med Chem; 2010 Feb; 53(4):1458-64. PubMed ID: 20128595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR.
    Lamar J; Hu J; Bueno AB; Yang HC; Guo D; Copp JD; McGee J; Gitter B; Timm D; May P; McCarthy J; Chen SH
    Bioorg Med Chem Lett; 2004 Jan; 14(1):239-43. PubMed ID: 14684335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of highly selective β-secretase inhibitors: synthesis, biological evaluation, and protein-ligand X-ray crystal structure.
    Ghosh AK; Venkateswara Rao K; Yadav ND; Anderson DD; Gavande N; Huang X; Terzyan S; Tang J
    J Med Chem; 2012 Nov; 55(21):9195-207. PubMed ID: 22954357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of 2-amino-imidazol-4-one derivatives as potent β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) inhibitors.
    Fan TY; Wu WY; Yu SP; Zhong Y; Zhao C; Chen M; Li HM; Li NG; Chen Z; Chen S; Sun ZH; Duan JA; Shi ZH
    Bioorg Med Chem Lett; 2019 Dec; 29(24):126772. PubMed ID: 31711785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.